O'Hagan D, Singh M, Ugozzoli M, Wild C, Barnett S, Chen M, Schaefer M, Doe B, Otten G R, Ulmer J B
Vaccines Research, Chiron Corporation, Emeryville, California 94608, USA. derek_o'
J Virol. 2001 Oct;75(19):9037-43. doi: 10.1128/JVI.75.19.9037-9043.2001.
The effectiveness of cationic microparticles with adsorbed DNA at inducing immune responses was investigated in mice, guinea pigs, and rhesus macaques. Plasmid DNA vaccines encoding human immunodeficiency virus (HIV) Gag and Env adsorbed onto the surface of cationic poly(lactide-coglycolide) (PLG) microparticles were shown to be substantially more potent than corresponding naked DNA vaccines. In mice immunized with HIV gag DNA, adsorption onto PLG increased CD8(+) T-cell and antibody responses by approximately 100- and approximately 1,000-fold, respectively. In guinea pigs immunized with HIV env DNA adsorbed onto PLG, antibody responses showed a more rapid onset and achieved markedly higher enzyme-linked immunosorbent assay and neutralizing titers than in animals immunized with naked DNA. Further enhancement of antibody responses was observed in animals vaccinated with PLG/DNA microparticles formulated with aluminum phosphate. The magnitude of anti-Env antibody responses induced by PLG/DNA particles was equivalent to that induced by recombinant gp120 protein formulated with a strong adjuvant, MF-59. In guinea pigs immunized with a combination vaccine containing HIV env and HIV gag DNA plasmids on PLG microparticles, substantially superior antibody responses were induced against both components, as measured by onset, duration, and titer. Furthermore, PLG formulation overcame an apparent hyporesponsiveness of the env DNA component in the combination vaccine. Finally, preliminary data in rhesus macaques demonstrated a substantial enhancement of immune responses afforded by PLG/DNA. Therefore, formulation of DNA vaccines by adsorption onto PLG microparticles is a powerful means of increasing vaccine potency.
研究了吸附有DNA的阳离子微粒在小鼠、豚鼠和恒河猴中诱导免疫反应的有效性。编码人类免疫缺陷病毒(HIV)Gag和Env的质粒DNA疫苗吸附到阳离子聚(丙交酯-共-乙交酯)(PLG)微粒表面后,显示出比相应的裸DNA疫苗更有效的效果。在用HIV gag DNA免疫的小鼠中,吸附到PLG上使CD8(+) T细胞反应和抗体反应分别增加了约100倍和约1000倍。在用吸附到PLG上的HIV env DNA免疫的豚鼠中,抗体反应的起效更快,酶联免疫吸附测定和中和效价比用裸DNA免疫的动物显著更高。在用磷酸铝配制的PLG/DNA微粒接种的动物中观察到抗体反应进一步增强。PLG/DNA颗粒诱导的抗Env抗体反应强度与用强佐剂MF-59配制的重组gp120蛋白诱导的反应强度相当。在用含有PLG微粒上的HIV env和HIV gag DNA质粒的联合疫苗免疫的豚鼠中,针对两种成分诱导的抗体反应在起效、持续时间和效价方面均显著更优。此外,PLG制剂克服了联合疫苗中env DNA成分明显的低反应性。最后,恒河猴的初步数据表明PLG/DNA能显著增强免疫反应。因此,通过吸附到PLG微粒上配制DNA疫苗是提高疫苗效力的有力手段。